Baxter Oncology GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding, Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
12
SFDA:6
NMPA:3
PHILIPPINES:3
Drug Approvals
Fludarabine Phosphate for Injection
- Product Name
- 福达华
- Approval Number
- J20140131
- Approval Date
- Jun 1, 2020
NMPA
Fludarabine Phosphate for Injection
- Product Name
- 福达华
- Approval Number
- 国药准字J20140131
- Approval Date
- Jun 1, 2020
NMPA
Clinical Trials
No trials found
News
No news found